A50V (p.Ala50Val) variant of TNXB (Tenascin-X)
A50V (p.Ala50Val) in TNXB (Tenascin-X) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.27 / 1. The record also includes structural context.
A50V (p.Ala50Val) variant details
- p.Ala50Val
- NCI-TCGA Cosmic COSV6448
- cosmic curated COSV64483
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.268
- ESM-1b 0.00
- AlphaMissense 0.10
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available